The time to create true and lasting transformation in clinical trials is now. Together, we can harness our experiences and momentum from COVID-19 to shape a future of smarter, faster research.
CTTI’s vision, Transforming Trials 2030, is that clinical trials in 2030 will be:
And the key to achieving this vision is YOU.
Cross-system collaboration is critical to unlocking the change that we’ve talked about in the research community for so long. Today, we ask you to commit to making Transforming Trials 2030 a reality.
“We collaborate with all stakeholders to ensure innovative and nimble IRB processes for e-consenting and decentralized clinical trials. We remain committed to ensure the protocol requires only essential study activities and the informed consent and related materials are clear, concise, and easily understood by trial participants.” –Priscilla Short, Salus IRB
“We foresee the future of how patients interact with both general medical care, and clinical research, to be in a more flexible and personalised way. That means for some cases, we will see more distributed settings for trials, and in the end we will be able to choose how we best wish to receive our care and participate in clinical trials. In addition, we are enthusiastic to be part of the paradigm shift in the way we assess patients – by using digital, objective, and real-world based measurements to generate more meaningful data to both patients and researchers alike.” – Sam Hariry, Novartis Institutes for Biomedical Research